CN104042970A - Traditional Chinese medicine (TCM) composition for allergic purpura - Google Patents
Traditional Chinese medicine (TCM) composition for allergic purpura Download PDFInfo
- Publication number
- CN104042970A CN104042970A CN201410316678.0A CN201410316678A CN104042970A CN 104042970 A CN104042970 A CN 104042970A CN 201410316678 A CN201410316678 A CN 201410316678A CN 104042970 A CN104042970 A CN 104042970A
- Authority
- CN
- China
- Prior art keywords
- parts
- radix
- chinese medicine
- treatment
- medicine composition
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The invention relates to a traditional Chinese medicine (TCM) composition for treating allergic purpura. The composition is prepared from the following active pharmaceutical ingredients in parts by weight: 22-28 parts of cogon grass rhizome, 22-28 parts of lithospermum erythrorhizon, 22-28 parts of spreading hedyotis herb, 22-28 parts of radix rehmanniae, 22-28 parts of giant knotweed rhizome, 16-20 parts of radix astragali, 16-20 parts of flos sophorae, 16-20 parts of motherwort herb, 9-15 parts of radix paeoniae rubra, 9-15 parts of liquorice, 9-15 parts of hirsute shiny bugleweed herb, 9-15 parts of weeping forsythia capsule, 9-15 parts of divaricate saposhnikovia root, 9-15 parts of tree peony root bark, 9-15 parts of peach kernels, 9-15 parts of talcum and 9-15 parts of India madder root. The composition has the advantages of stable curative effects and no side effects.
Description
Technical field
The present invention relates to technical field of Chinese medicines, particularly relate to a kind of Chinese medicine composition for the treatment of anaphylactoid purpura.
Background technology
Anaphylactoid purpura is by injury of small vessels, and blood oozes between skin, the disease of cutaneous manifestations point-like or the livid purple speckle of lamellar.Clinical symptoms is: the visible point-like of whole body or extremity or speckle shape are hemorrhage, do not exceed skin, and outbreak, or hemorrhage speckle repeatedly slightly exceeds skin, and color is scarlet or dark red, and micro-itching can accompany the diseases such as stomachache or joint aches; Can accompany low grade fever, bleeding from the gum, epistaxis, menorrhagia, can there is headache in severe patient, stupor, has blood in stool, hematuria.
At present, the medicine for the treatment of anaphylactoid purpura is more, but has the deficiencies such as curative effect is unstable, side effect is large.
Summary of the invention
The technical problem to be solved in the present invention is: for solving the deficiencies in the prior art, the invention provides a kind of Chinese medicine composition for the treatment of anaphylactoid purpura, the present invention has advantages of stable curative effect, has no side effect.
Treat a Chinese medicine composition for anaphylactoid purpura, by the crude drug of following weight portion, made: Rhizoma Imperatae 22-28 part, Radix Arnebiae (Radix Lithospermi) 22-28 part, Herba Hedyotidis Diffusae 22-28 part, Radix Rehmanniae 22-28 part, Rhizoma Polygoni Cuspidati 22-28 part, Radix Astragali 16-20 part, Flos Sophorae 16-20 part, Herba Leonuri 16-20 part, Radix Paeoniae Rubra 9-15 part, Radix Glycyrrhizae 9-15 part, Herba Lycopi 9-15 part, Fructus Forsythiae 9-15 part, Radix Saposhnikoviae 9-15 part, Cortex Moutan 9-15 part, Semen Persicae 9-15 part, Talcum 9-15 part, Radix Rubiae 9-15 part.
The Chinese medicine composition of described treatment anaphylactoid purpura, it is preferably made by the crude drug of following weight portion: 25 parts of Rhizoma Imperataes, 25 parts of Radix Arnebiae (Radix Lithospermi)s, 25 parts of Herba Hedyotidis Diffusaes, 25 parts of Radix Rehmanniae, 25 parts of Rhizoma Polygoni Cuspidati, 18 parts of the Radixs Astragali, 18 parts, Flos Sophorae, 18 parts of Herba Leonuris, 12 parts of Radix Paeoniae Rubra, 12 parts, Radix Glycyrrhizae, 12 parts of Herba Lycopi, 12 parts of Fructus Forsythiaes, Radix Saposhnikoviae 12,12 parts of Cortex Moutans, 12 parts, Semen Persicae, 12 parts, Talcum, 12 parts, Radix Rubiae.
The preparation method of the Chinese medicine composition of described treatment anaphylactoid purpura is: Chinese medicinal preparation method is routinely made and is suitable for medicinal oral drugs.
The application of the Chinese medicine composition of described treatment anaphylactoid purpura in preparation treatment allergy purpura.
The beneficial effect that the present invention compared with prior art had is: the present invention is under Traditional Chinese medical theory and clinical experience guidance, chooses each crude drug and proportioning thereof, has the function of loose wind dampness removing, cooling blood and removing stasis, realizes the object for the treatment of anaphylactoid purpura.The present invention has advantages of stable curative effect, has no side effect.
Below in conjunction with clinical experiment, beneficial effect of the present invention is described:
(1) clinical data: the present invention treats patients with anaphylactoid purpura 68 examples altogether, wherein, male 27 examples, female's 41 examples, the age is 9-45 year.
(2) Therapeutic Method: the oral drugs that Chinese medicine composition of the present invention is made can be decoction, tablet, pill and capsule etc., take decoction as example, 1 pair of every day, minute takes for 2 times, early, respectively take 1 evening, within 10 days, is 1 course for the treatment of.
(3) the standard of curative effect evaluation:
Cure: the purple point of purpura and General Symptoms disappear, and it is normal that lab index is recovered.
Take a turn for the better: cyanosis of the skin speckle obviously reduces, and General Symptoms alleviates, and lab index is improved.
Do not heal: cyanosis of the skin speckle, General Symptoms and lab index are all unchanged.
(4) therapeutic outcome: the present invention treats patients with anaphylactoid purpura 68 examples altogether, through 1-3 course of therapy, cures 63 examples, accounts for 92.6%, and 5 examples that take a turn for the better, account for 7.4%, and effective percentage is 100%, has no any side effect; Cure in 63 examples, cure 14 examples 1 course for the treatment of, cure 22 examples 2 courses for the treatment of, cure 27 examples 3 courses for the treatment of, follows up a case by regular visits to half by 1 year after healing, is showed no recurrence; Result shows, the present invention has advantages of stable curative effect, has no side effect.
(5) model case:
1, Zhu, man, 10 years old, two lower limb aubergine speckles, that presses does not fade, and increases gradually, and platelet count is normal.Examine as anaphylactoid purpura.Take Chinese medicine composition of the present invention and cure 1 course for the treatment of, after half a year, follow up a case by regular visits to, not recurrence.
2, Jiang, female, 47 years old, two lower limb aubergine speckles, pruritus, stomachache.Take Chinese medicine composition of the present invention and cure 3 courses for the treatment of, after 1 year, follow up a case by regular visits to, not recurrence.
The specific embodiment
Embodiment 1:
Treat a Chinese medicine composition for anaphylactoid purpura, by the crude drug of following weight portion, made: 22 parts of Rhizoma Imperataes, 22 parts of Radix Arnebiae (Radix Lithospermi)s, 22 parts of Herba Hedyotidis Diffusaes, 22 parts of Radix Rehmanniae, 22 parts of Rhizoma Polygoni Cuspidati, 16 parts of the Radixs Astragali, 16 parts, Flos Sophorae, 16 parts of Herba Leonuris, 9 parts of Radix Paeoniae Rubra, 9 parts, Radix Glycyrrhizae, 9 parts of Herba Lycopi, 9 parts of Fructus Forsythiaes, 9 parts of Radix Saposhnikoviaes, 9 parts of Cortex Moutans, 9 parts, Semen Persicae, 9 parts, Talcum, 9 parts, Radix Rubiae.
Its preparation method is: Chinese medicinal preparation method is routinely made and is suitable for medicinal oral drugs.
Embodiment 2:
Treat a Chinese medicine composition for anaphylactoid purpura, by the crude drug of following weight portion, made: 25 parts of Rhizoma Imperataes, 25 parts of Radix Arnebiae (Radix Lithospermi)s, 25 parts of Herba Hedyotidis Diffusaes, 25 parts of Radix Rehmanniae, 25 parts of Rhizoma Polygoni Cuspidati, 18 parts of the Radixs Astragali, 18 parts, Flos Sophorae, 18 parts of Herba Leonuris, 12 parts of Radix Paeoniae Rubra, 12 parts, Radix Glycyrrhizae, 12 parts of Herba Lycopi, 12 parts of Fructus Forsythiaes, Radix Saposhnikoviae 12,12 parts of Cortex Moutans, 12 parts, Semen Persicae, 12 parts, Talcum, 12 parts, Radix Rubiae.
Its preparation method is: Chinese medicinal preparation method is routinely made and is suitable for medicinal oral drugs.
Embodiment 3:
Treat a Chinese medicine composition for anaphylactoid purpura, by the crude drug of following weight portion, made: 28 parts of Rhizoma Imperataes, 28 parts of Radix Arnebiae (Radix Lithospermi)s, 28 parts of Herba Hedyotidis Diffusaes, 28 parts of Radix Rehmanniae, 28 parts of Rhizoma Polygoni Cuspidati, 20 parts of the Radixs Astragali, 20 parts, Flos Sophorae, 20 parts of Herba Leonuris, 15 parts of Radix Paeoniae Rubra, 15 parts, Radix Glycyrrhizae, 15 parts of Herba Lycopi, 15 parts of Fructus Forsythiaes, 15 parts of Radix Saposhnikoviaes, 15 parts of Cortex Moutans, 15 parts, Semen Persicae, 15 parts, Talcum, 15 parts, Radix Rubiae.
Its preparation method is: Chinese medicinal preparation method is routinely made and is suitable for medicinal oral drugs.
Claims (4)
1. a Chinese medicine composition for the treatment of anaphylactoid purpura, is characterized in that: the crude drug by following weight portion is made: Rhizoma Imperatae 22-28 part, Radix Arnebiae (Radix Lithospermi) 22-28 part, Herba Hedyotidis Diffusae 22-28 part, Radix Rehmanniae 22-28 part, Rhizoma Polygoni Cuspidati 22-28 part, Radix Astragali 16-20 part, Flos Sophorae 16-20 part, Herba Leonuri 16-20 part, Radix Paeoniae Rubra 9-15 part, Radix Glycyrrhizae 9-15 part, Herba Lycopi 9-15 part, Fructus Forsythiae 9-15 part, Radix Saposhnikoviae 9-15 part, Cortex Moutan 9-15 part, Semen Persicae 9-15 part, Talcum 9-15 part, Radix Rubiae 9-15 part.
2. the Chinese medicine composition for the treatment of anaphylactoid purpura according to claim 1, is characterized in that: the crude drug by following weight portion is made: 25 parts of Rhizoma Imperataes, 25 parts of Radix Arnebiae (Radix Lithospermi)s, 25 parts of Herba Hedyotidis Diffusaes, 25 parts of Radix Rehmanniae, 25 parts of Rhizoma Polygoni Cuspidati, 18 parts of the Radixs Astragali, 18 parts, Flos Sophorae, 18 parts of Herba Leonuris, 12 parts of Radix Paeoniae Rubra, 12 parts, Radix Glycyrrhizae, 12 parts of Herba Lycopi, 12 parts of Fructus Forsythiaes, Radix Saposhnikoviae 12,12 parts of Cortex Moutans, 12 parts, Semen Persicae, 12 parts, Talcum, 12 parts, Radix Rubiae.
3. the preparation method of the Chinese medicine composition for the treatment of anaphylactoid purpura according to claim 1 and 2, is characterized in that: Chinese medicinal preparation method is routinely made and is suitable for medicinal oral drugs.
4. the application of the Chinese medicine composition for the treatment of anaphylactoid purpura according to claim 1 and 2 in preparation treatment allergy purpura.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201410316678.0A CN104042970A (en) | 2014-07-06 | 2014-07-06 | Traditional Chinese medicine (TCM) composition for allergic purpura |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201410316678.0A CN104042970A (en) | 2014-07-06 | 2014-07-06 | Traditional Chinese medicine (TCM) composition for allergic purpura |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN104042970A true CN104042970A (en) | 2014-09-17 |
Family
ID=51496693
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201410316678.0A Pending CN104042970A (en) | 2014-07-06 | 2014-07-06 | Traditional Chinese medicine (TCM) composition for allergic purpura |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN104042970A (en) |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN104667020A (en) * | 2015-03-20 | 2015-06-03 | 孙号 | Pharmaceutical composition for treating anaphylactoid purpura and preparation method of pharmaceutical composition |
| CN106377691A (en) * | 2016-10-27 | 2017-02-08 | 谭奇纹 | Traditional Chinese medicine capable of treating anaphylactoid purpura |
Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102526514A (en) * | 2011-11-12 | 2012-07-04 | 赵增 | Medicine used for treating allergic purpura |
| CN102614305A (en) * | 2012-05-01 | 2012-08-01 | 马守云 | Medicament for treating allergic purpura |
| CN102755553A (en) * | 2012-07-17 | 2012-10-31 | 王珉鑫 | Sinkiang arnebia root-honeysuckle flower-red paeony root-Chinese arborvitae twig soup for treating allergic purpura |
| CN103083570A (en) * | 2012-12-11 | 2013-05-08 | 宋协勘 | Traditional Chinese medicine for treating anaphylactoid purpura |
-
2014
- 2014-07-06 CN CN201410316678.0A patent/CN104042970A/en active Pending
Patent Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102526514A (en) * | 2011-11-12 | 2012-07-04 | 赵增 | Medicine used for treating allergic purpura |
| CN102614305A (en) * | 2012-05-01 | 2012-08-01 | 马守云 | Medicament for treating allergic purpura |
| CN102755553A (en) * | 2012-07-17 | 2012-10-31 | 王珉鑫 | Sinkiang arnebia root-honeysuckle flower-red paeony root-Chinese arborvitae twig soup for treating allergic purpura |
| CN103083570A (en) * | 2012-12-11 | 2013-05-08 | 宋协勘 | Traditional Chinese medicine for treating anaphylactoid purpura |
Non-Patent Citations (1)
| Title |
|---|
| 刘建平主编: "过敏性紫癜", 《当代内科名方验方大全》 * |
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN104667020A (en) * | 2015-03-20 | 2015-06-03 | 孙号 | Pharmaceutical composition for treating anaphylactoid purpura and preparation method of pharmaceutical composition |
| CN104667020B (en) * | 2015-03-20 | 2018-06-05 | 新乡医学院第一附属医院 | A kind of pharmaceutical composition for treating anaphylactoid purpura and preparation method thereof |
| CN106377691A (en) * | 2016-10-27 | 2017-02-08 | 谭奇纹 | Traditional Chinese medicine capable of treating anaphylactoid purpura |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN103386086A (en) | Traditional Chinese medicine composition for treating dysmenorrhea and preparation method thereof | |
| CN103316174B (en) | Traditional Chinese medicinal composition for treating acute cholecystitis and preparation method thereof | |
| CN103393966B (en) | A kind of Chinese medicine composition for the treatment of menoxenia | |
| CN103356916A (en) | Traditional Chinese medicinal composition for treating retrograde menstruation | |
| CN103083476B (en) | Traditional Chinese medicine for treating acute mastitis | |
| CN103655989A (en) | Traditional Chinese medicine for external use for treating rheumatic arthritis | |
| CN103356968B (en) | Traditional Chinese medicine composition for treating endometriosis | |
| CN103446554A (en) | Traditional Chinese medicine composition for treating scapulohumeral periarthritis | |
| CN103356969A (en) | Traditional Chinese medicine composition for treating hysteromyoma | |
| CN102430071A (en) | Medicament for treating herpes zoster | |
| CN103341037B (en) | Traditional Chinese medicine composition for treating azoospermia | |
| CN103550643A (en) | Traditional Chinese medicine for treating tuberculosis | |
| CN103356925B (en) | Traditional Chinese medicine composition for treating sperm non-liquified symptom | |
| CN104042970A (en) | Traditional Chinese medicine (TCM) composition for allergic purpura | |
| CN103330928B (en) | Traditional Chinese medicine composition used for treating gastric ulcer and preparation method thereof | |
| CN103341153A (en) | Traditional Chinese medicine composition for treating raynaud disease | |
| CN102631450A (en) | Traditional Chinese medicine (TCM) decoction for treating wind-cold type common cold | |
| CN103800664A (en) | Traditional Chinese medicine composition for treating menopausal syndrome | |
| CN103800746A (en) | Traditional Chinese medicine composition for treating acute pelvic inflammation | |
| CN103800761A (en) | Traditional Chinese medicine composition for treating cervicitis | |
| CN104800599A (en) | Traditional Chinese medicinal composition for treating deficiency of kidney-yin | |
| CN104056136A (en) | Traditional Chinese medicine composition for treating verruca plana | |
| CN102631568B (en) | Pills for treating cervical spondylosis | |
| CN103735955B (en) | The medicine for the treatment of pulmonary carcinoma | |
| CN103751469A (en) | Composition for treating qi and blood stasis type systemic scleroderma |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20140917 |
|
| RJ01 | Rejection of invention patent application after publication |